This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Clinical Trials

Basil M. Rifkind, MD, FRCP; Robert I. Levy, MD

Arch Surg. 1978;113(1):80-83.

Abstract
• It is generally accepted that we still lack a conclusive answer, to whether lowering of the lipid level will prevent the development or reverse the progression of coronary atherosclerosis. Multiple risk factor intervention trials now have the merit of addressing themselves to probable and practical needs for intervening on several of the major risk factors to obtain the maximum impact on populations at risk.

(Arch Surg 113:80-83, 1978)

Author Affiliations
From the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.

Footnotes
Accepted for publication July 1, 1977.

Reprint requests to National Heart, Lung, and Blood Institute, Bldg 31, Room 5A52, Bethesda, MD 20014 (Dr Levy).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?